FDA: Preliminary Injunction Not Needed In GLP-1 Compounding Pharmacies’ Suit
FORT WORTH, Texas — The U.S. Food and Drug Administration opposed a motion for a preliminary injunction filed by companies representing the interests of drug compounders that challenge the U.S. Food...To view the full article, register now.
Already a subscriber? Click here to view full article